Kent Hoskins, MD


Department of Medicine, Division of Hematology/Oncology

College of Medicine

Research Program

Translational Oncology Program (TO)

Phone: 312-996-1581

Email: [email protected]

Kent Hoskins, MD, was appointed Oncology Service Line Medical Director at UI Health in 2023. In this role, Hoskins is the executive leader responsible for creating and implementing business plans at the University of Illinois Hospital & Clinics and the Cancer Center to grow oncology services across the UI Health enterprise. Reporting both to Cancer Center Director Jan Kitajewski, PhD, and Hospital & Clinics Chief Medical Officer Jon Radosta, MD, FACP, Hoskins will develop and drive oncology care strategies to advance excellence in care for patients with cancer at UI Health.

.A Cancer Center member since 2012, Hoskins’ research is focused on breast cancer, genetics, risk assessment and racial disparities. He is the Eileen Lindsay Heidrick Professor in Oncology and a Professor of Medicine in the division of Hematology and Oncology at the University of Illinois College of Medicine. Hoskins, as the director of the UI Health Familial Breast Cancer Program in the Division of Hematology/Oncology and co-Lead of the Hereditary Cancer group in the Cancer Center, focuses on the assessment of breast cancer risk. Utilizing both population studies, behavioral and molecular approaches, he has developed strategies to reduce breast cancer mortality by better identifying high-risk individuals. He also examines the disparity in breast cancer mortality between African American women and those of other racial and ethnic groups, paying particular attention to the roles of social determinants of health and disproportionately aggressive tumor biology among African American women. In his work, Hoskins strives to understand the ethical, psychosocial and behavioral issues in personalized medicine and cancer risk prediction for minority women. Hoskins also has served as the Cancer Center Associate Director for Translational Oncology. He was co-leader of the Cancer Center’s Breast Cancer Working Group and established several racially diverse biospecimen resources that are now widely used by cancer center members. He is also actively involved in developing clinical trials in breast cancer and in developing novel approaches for analyzing biospecimens collected from clinical trial participants to identify mechanisms of drug resistance. Hoskins is board-certified in Medical Oncology.


MD, The University of Iowa College of Medicine

Published Research

PubMed Search

Other Link(s)

Department Webpage

Translate »